Rick Dimaggio’s Post

For years, patient centricity has primarily focused on healthcare providers. Initially more of a buzzword than a practice, there's now a significant movement to actively involve patients in their care. This shift spans provider medicine, pharmaceutical R&D, and insurance payers, emphasizing personalized medicine, better treatment outcomes, and consumer experience. This blog discusses why patient centricity matters in healthcare and the role of data management in achieving its benefits. #NetApp #ONTAP #DataManagement

By leveraging data, clinical expertise, and digital tools, healthcare payers and pharmaceutical companies can collaborate to improve patient journeys and treatment management in value-based care for chronic diseases. A collaborative, VBC-oriented approach using virtual care models can personalize care delivery, optimize resource allocation, and ultimately improve patient outcomes. #ValueBasedCare #Healthcare #VBC

Explore the synergy of HCP engagement and patient centricity in pharma. Discover how this intersection improves outcomes, enhances trust, and drives personalized care. #Pharma #PatientCare #HCPEngagement https://lnkd.in/gAE6bTVg

Patients want access to affordable therapy. Pharma brands want patients to access their therapies. So, what’s standing in the way? Fragmentation and manual processes currently create barriers between pharma companies, providers, payers, and pharmacies. So how can we lower those barriers to help patients get therapies faster? In his latest @Drug Channels post, @Kevin Kettler explores how @CoverMyMeds helps pharma brands remove barriers to collaboration with providers, payers, and pharmacies. Read more: https://lnkd.in/e2Wq8yci #NoBarriers

Patients want access to affordable therapy. Pharma brands want patients to access their therapies. So, what’s standing in the way? Fragmentation and manual processes currently create barriers between pharma companies, providers, payers, and pharmacies. So how can we lower those barriers to help patients get therapies faster? In his latest @Drug Channels post, @Kevin Kettler explores how @CoverMyMeds helps pharma brands remove barriers to collaboration with providers, payers, and pharmacies. Read more: https://lnkd.in/eXgypZ2V #NoBarriers

Patients want access to affordable therapy. Pharma brands want patients to access their therapies. So, what’s standing in the way? Fragmentation and manual processes currently create barriers between pharma companies, providers, payers, and pharmacies. So how can we lower those barriers to help patients get therapies faster? In his latest @Drug Channels post, @Kevin Kettler explores how @CoverMyMeds helps pharma brands remove barriers to collaboration with providers, payers, and pharmacies. Read more: https://lnkd.in/ebris-Yv #NoBarriers

Today’s patients have evolved beyond mere medication. They want to actively participate in their #healthcarejourney, access all the information about the drug and its impact on their health conditions, and stay connected to their care providers for instant support. On the other hand, #pharmaceutical companies have also realized the care gap and started expanding Patient support programs (PSPs) to improve patient outcomes and foster loyalty. Such as - ~ Personalized digital solutions alongside the drug that help patients optimize their medication outcomes ~ Personalized in-person support services that cater to patients’ unique health conditions, ensuring convenient and timely access, utilization, and adherence. But how can Pharma further utilize #digitalhealthsolutions, such as patient or companion apps, to close the gap between patient needs and expectations? To find out more, check out our latest blog post: https://lnkd.in/dXzZtmEY #patientexperience #patientcentricity #patientsupport #newpagesolutions

Patients want access to affordable therapy. Pharma brands want patients to access their therapies. So, what’s standing in the way? Fragmentation and manual processes currently create barriers between pharma companies, providers, payers, and pharmacies. So how can we lower those barriers to help patients get therapies faster? In his latest @Drug Channels post, Kevin Kettler explores how CoverMyMeds helps pharma brands remove barriers to collaboration with providers, payers, and pharmacies. Read more: https://lnkd.in/dhinV2iX #NoBarriers 

Patient support programs play a crucial role in helping individuals manage their conditions and adhere to treatment regimens. Despite investing over $5.7 billion (about $18 per person in the US) by the pharmaceutical industry in patient support programs, the utilization of these programs remains lower than 5%. To better understand the dynamics at play, Phreesia conducted a comprehensive survey to assess patient awareness, usage, and perceptions of support programs. The survey included 4,869 participants, with a majority under 65 years old (69%) and female (65%). Notably, 69% of respondents were on medication, reflecting a relevant sample for evaluating patient support programs. Key findings include: ·      Patient Needs: 79% of patients who value support programs found specific ones helpful. ·      Low Usage and Familiarity: Only 8% of patients reported having used such programs, and a mere 3% were currently using them. This low utilization can be attributed to a significant lack of familiarity: 59% of patients had little to no knowledge of these programs. ·       Usage Patterns: Patients typically engage with these resources during key moments in their treatment journey, such as starting a new medication, receiving a first diagnosis, or switching medications. However, 61% of patients do not perceive much value in these programs, suggesting that existing support services may not fully meet patient needs or expectations. ·      Desired Support Services: Patients expressed a desire for more support, particularly in areas such as medication adherence, emotional support, and educational resources. ·      Awareness Channels: There is a significant opportunity to expand and optimize the channels through which patients learn about support programs. While 44% of patients learned about support programs online, a majority (55%) still preferred to receive this information from their doctors. The lack of awareness and underutilization of patient support programs highlights the urgent need for improved efforts from healthcare providers and pharmaceutical companies. Tailored marketing campaigns, integrated omnichannel plans, and enhanced online experiences can significantly increase awareness and access to these programs. Also, partnering with pharmacies for educational outreach and expanding support services for continuous patient assistance can enhance these initiatives' effectiveness. #Pharmaceuticals #Healthcare #PatientCentricity #PatientEngagement #PatientProgram

3 Principles to Optimize Patient Support Programs Introduction Pharmaceutical companies are undergoing a profound transformation. No longer confined to merely developing treatments, companies are assuming a partnership role to collaborate with healthcare providers and patients through their healthcare journey to foster optimal outcomes. Many patient support programs remain underutilized. Addressing this challenge requires constant analysis and optimization. 3 Principles of Effective Patient Support Programs This is usually done through focus groups, patient discussions: 1. Measure to understand. The first step requires understanding the most imperative unmet needs of the patient and establishing baselines, objectives, and services to address them. 2. Listen to what patients and HCPs tell you and act on the right information. This is key in ensuring your patient support program is part of the connected care ecosystem. Addressing obstacles with simple, common-sense solutions often has a bigger impact than complex behavioral analysis. 3. Embrace partnerships. Some of the most refreshing and promising alliances are pharmaceutical companies teaming up to provide best-in-class agnostic health technology tools and solutions. Next, Apply Best Practices Improving adherence takes rigor. Among the go-to strategies leading pharmaceutical companies use the following: Avoid generic language. Communications that are market-tailored, based on regulatory and cultural differences, are more relevant. Put the patient first Patients are not passive recipients of medical interventions understanding and addressing evolving needs with the right solutions through personalization increases engagement. Cover all stakeholders in the care journey. Complete patient-centricity requires collaboration with healthcare providers, insurers, and caregivers to understand the entire ecosystem and its role in the patient journey. Cover all enrollment opportunities. Make it easy for patients to find you, invited into the program, from doctor visits to refill triggers, posters in waiting rooms, to online disease-related content. Connect channels and people. Ensure the program information is delivered through channels tailored to the patient and health care professionals’ preferences. Treatment Adherence Requires Connected Care Recognizing patients as active participants, tailoring support programs to their unique needs, and creating a connected care ecosystem will improve adherence and overall healthcare outcomes. Conclusion Connecting patients to their care team, relevant disease management tools, and a community of other patients living with the same condition all help to create a connected care ecosystem. #PatientSupportMarketing #PatientEngagement #PharmaMarketing https://lnkd.in/ewd2RnEy